WALPHARMA

WALPHARMA has been active since 1990 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 1 administrative register entry (see administrative flags). The 2024 annual accounts show equity of €98,407 and a net result of -€27,936. Equity is shrinking by about 19% per year across the filed financial years. Its solvency ranks better than 64% of 25,599 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 0.9% (low).